A multicenter, randomized, controlled trial of S-1/Cisplatin vs. Docetaxel/Cisplatin for treatment of untreated advanced lung cancer

Trial Profile

A multicenter, randomized, controlled trial of S-1/Cisplatin vs. Docetaxel/Cisplatin for treatment of untreated advanced lung cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 20 May 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Docetaxel
  • Indications Non-small cell lung cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Taiho Pharmaceutical
  • Most Recent Events

    • 16 Oct 2015 New source identified and integrated (JapicCTI111479).
    • 16 Oct 2015 New trial record
    • 06 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top